Friday 6 November 2026
Export TDOC’s income statement to Excel — free account
Teladoc Health, Inc.
TDOC Healthcare Health Information Services
Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024.
- Revenue
- −3.41%
- EPS
- +47.1%
- Free cash flow
- +11.8%
- Total debt
- +0.36%
Quarter to September 2026, against a year earlier
8.78
0.63
−6.70%
Follow TDOC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 5 | 5 |
| (13.93%) | (12.39%) | (12.99%) | (11.52%) | ||
| (6.28%) | (5.48%) | (6.28%) | (5.48%) | ||
ROIC |
(10.27%) | (8.07%) | (7.62%) | (7.06%) | |
Return on Tangible Assets |
(27.02%) | (22.71%) | 85.01% | 93.78% | |
Average Days of Receivables |
27.82 | 31.01 | 32.40 | 34.15 | |
Free Cash Flow per Share |
0.78 | 0.87 | 0.49 | 0.69 | |
Free Cash Flow |
137.33 | 156.26 | 88.56 | 126.12 | |
Capital Expenditures |
(157.02) | (131.69) | (172.62) | (142.26) | |
| Other line items | |||||
Cash ROIC |
4.34% | 5.07% | 2.87% | 4.01% | |
Accounts Receivable Turnover |
12.43 | 11.26 | 11.15 | 11.18 | |
Accounts Payable Turnover |
19.03 | 15.88 | 16.81 | 15.74 | |
Inventory Turnover |
20.21 | 22.20 | 23.07 | 21.96 | |
Average Days of Payables |
22.69 | 21.36 | 17.71 | 21.81 | |
Days of Inventory on Hand |
18.07 | 14.91 | 13.62 | 14.47 | |
Tax Rate |
(0.15) | (0.08) | (0.03) | (0.02) | |
Research and Development Expense of Revenue |
10.99% | 10.97% | 10.84% | 10.85% | |
Selling, General and Administrative Expense of Revenue |
50.58% | 49.91% | 49.26% | 48.15% | |
Share Based Compensation of Revenue |
3.18% | 2.78% | 2.28% | 2.08% | |
Interest Coverage |
(13.34) | (10.57) | (9.36) | (8.00) | |
Operating CF/Net income |
(1.47) | (1.68) | (1.47) | (1.73) | |
Depreciation/Fixed assets |
16.62 | 14.96 | 15.82 | 15.48 | |
Capex/Depreciation |
(0.35) | (0.33) | (0.44) | (0.38) | |
Revenue per Share |
14.36 | 14.04 | 13.75 | 13.57 | |
Operating CF per Share |
1.67 | 1.61 | 1.44 | 1.48 | |
Capex per Share |
(0.89) | (0.74) | (0.95) | (0.78) | |
Capex to Sales |
0.06 | 0.05 | 0.07 | 0.06 |
Columns are period end dates · fundamentals updated 2 Nov 2026